Human endogenous retrovirus HERV-Fc1 association with multiple sclerosis susceptibility: a meta-analysis. by Belén de la Hera, Jezabel Varadé, Marta García-Montojo, Antonio Alcina, María Fedetz, Iraide Alloza, Ianire Astobiza, Laura Leyva, Oscar Fernández, Guillermo Izquierdo, Alfredo Antigüedad, Rafael Arroyo, Roberto Álvarez-Lafuente, Koen Vandenbroeck, Fuencisla Matesanz, Elena Urcelay

Get full text

First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis by Simona Toscano, Tim Spelman, Serkan Ozakbas, Raed Alroughani, Clara G. Chisari, Salvatore Lo Fermo, Alexandre Prat, Marc Girard, Pierre Duquette, Guillermo Izquierdo, Sara Eichau, Pierre Grammond, Cavit Boz, Tomas Kalincik, Yolanda Blanco, Katherine Buzzard, Olga Skibina, Maria Jose Sa, Anneke van der Walt, Helmut Butzkueven, Murat Terzi, Oliver Gerlach, Francois Grand'Maison, Matteo Foschi, Andrea Surcinelli, Michael Barnett, Alessandra Lugaresi, Marco Onofrj, Bassem Yamout, Samia J. Khoury, Julie Prevost, Jeannette Lechner-Scott, Davide Maimone, Maria Pia Amato, Daniele Spitaleri, Vincent Van Pesch, Richard Macdonell, Elisabetta Cartechini, Koen de Gans, Mark Slee, Tamara Castillo-Triviño, Aysun Soysal, Jose Luis Sanchez-Menoyo, Guy Laureys, Liesbeth Van Hijfte, Pamela McCombe, Ayse Altintas, Bianca Weinstock-Guttman, Eduardo Aguera-Morales, Masoud Etemadifar, Cristina Ramo-Tello, Nevin John, Recai Turkoglu, Suzanne Hodgkinson, Sarah Besora, Bart Van Wijmeersch, Ricardo Fernandez-Bolaños, Francesco Patti

Get full text